Yujiro Hata News Today : Breaking News, Live Updates & Top Stories | Vimarsana

IDEAYA In Clinical Trial Deal With Merck To Evaluate IDE161 With KEYTRUDA In Endometrial Cancer

IDEAYA In Clinical Trial Deal With Merck To Evaluate IDE161 With KEYTRUDA In Endometrial Cancer
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Yujiro hataStefan klotterBiosciences incMerck co incUs food drug administration fastMore such health newsDrug administration fast trackChief executive officerLassen sie

Ideaya stock gains on Merck clinical trial pact (NASDAQ:IDYA)

Ideaya stock gains on Merck clinical trial pact (NASDAQ:IDYA)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Yujiro hataSolution conceptsChalkboard background

IDEAYA Biosciences, Inc (NASDAQ:IDYA) is largely controlled by institutional shareholders who own 77% of the company

Key Insights Institutions' substantial holdings in IDEAYA Biosciences implies that they have significant influence over.

Yujiro hataBlackrock incBiosciences incInstitutional ownershipInstitutional investorsNdividual investors

IDEAYA Announces Clinical Study Collaboration with Gilead Sciences to Evaluate Trodelvy® and IDE397 Combination in MTAP-Deletion Bladder Cancer

Entered into Clinical Study Collaboration and Supply Agreement with Gilead to evaluate IDE397, IDEAYA s MAT2A inhibitor, in combination with sacituzumab-govitecan-hziy Gilead s Trop-2 directed ADC,.

Darrin beaupreYujiro hataAndres ruiz brisenoGilead sciences incBiosciences incExchange commissionClinical study collaborationSupply agreementGilead sciencesChief medical officerChief executive officerQuarterly reportInvestor relations

IDEAYA Biosciences (IDYA) enter collaboration with Gilead (GILD) to evaluate Trodelvy and IDE397 combo

IDEAYA Biosciences (IDYA) enter collaboration with Gilead (GILD) to evaluate Trodelvy and IDE397 combo
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Darrin beaupreYujiro hataIdeaya biosciences incGilead sciences incGilead sciencesChief medical officerChief executive officer